BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19797757)

  • 1. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
    Des Jarlais DC; Arasteh K; Hagan H; McKnight C; Perlman DC; Friedman SR
    Am J Public Health; 2009 Oct; 99 Suppl 2(Suppl 2):S445-51. PubMed ID: 19797757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?
    Des Jarlais D; Arasteh K; McKnight C; Feelemyer J; Hagan H; Cooper H; Campbell A; Tross S; Perlman D
    PLoS One; 2015; 10(5):e0126180. PubMed ID: 25965957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities.
    Amesty S; Rivera AV; Fuller CM
    Subst Use Misuse; 2011; 46(2-3):285-94. PubMed ID: 21303248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
    Friedman SR; Chapman TF; Perlis TE; Rockwell R; Paone D; Sotheran JL; Des Jarlais DC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):83-91. PubMed ID: 10534151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.
    Kottiri BJ; Friedman SR; Neaigus A; Curtis R; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2002 May; 30(1):95-104. PubMed ID: 12048369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Semaan S
    Am J Public Health; 2011 Jul; 101(7):1277-83. PubMed ID: 21566021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
    Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex, drugs, and syringe exchange in New York City: women's experiences.
    Paone D; Caloir S; Shi Q; Des Jarlais DC
    J Am Med Womens Assoc (1972); 1995; 50(3-4):109-14. PubMed ID: 7657943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.
    Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C
    AIDS Behav; 2013 Sep; 17(7):2501-9. PubMed ID: 23640654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
    Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
    Des Jarlais DC; Arasteh K; Friedman SR
    Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV risks and seroprevalence among Mexican American injection drug users in California.
    Martinez AN; Bluthenthal RN; Flynn NM; Anderson RL; Kral AH
    AIDS Behav; 2011 Jan; 15(1):95-102. PubMed ID: 20020194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection.
    Des Jarlais DC; Arasteh K; McKnight C; Perlman DC; Cooper HL; Hagan H
    PLoS One; 2013; 8(6):e66874. PubMed ID: 23825055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic.
    Broz D; Ouellet LJ
    Drug Alcohol Depend; 2008 Apr; 94(1-3):221-33. PubMed ID: 18242879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racialized risk environments in a large sample of people who inject drugs in the United States.
    Cooper HL; Linton S; Kelley ME; Ross Z; Wolfe ME; Chen YT; Zlotorzynska M; Hunter-Jones J; Friedman SR; Des Jarlais D; Semaan S; Tempalski B; DiNenno E; Broz D; Wejnert C; Paz-Bailey G;
    Int J Drug Policy; 2016 Jan; 27():43-55. PubMed ID: 26342272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037.
    Momplaisir F; Hussein M; Tobin-Fiore D; Smith L; Bennett D; Latkin C; Metzger DS
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):394-401. PubMed ID: 28816720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.